These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13673975)

  • 1. [Observation of bone marrow function in cytostatic treatment of malignant tumors].
    KRATZSCH E; SCHMERMUND HJ
    Med Klin; 1959 Jul; 54(27):1238-40. PubMed ID: 13673975
    [No Abstract]   [Full Text] [Related]  

  • 2. [Testing the resistance of human tumor and bone marrow cells to cytostatic agents].
    Kaufmann M; Kubli F
    Fortschr Med; 1978 Apr; 96(15):823-6. PubMed ID: 640566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lysozyme and cytostatic therapy].
    Neretto G; Giovanelli E; Agricola R; Pellegrino S; Bruno F; Mangione M; Furno F
    Clin Ter; 1978 Dec; 87(5):465-73. PubMed ID: 737983
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy with cytostatic drugs in the elderly].
    Sauer H
    Internist (Berl); 1991 Aug; 32(8):479-85. PubMed ID: 1938269
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stem cell kinetics of bone marrow in relation to cytostatic treatment].
    Laerum OD
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1207-9 passim. PubMed ID: 4935674
    [No Abstract]   [Full Text] [Related]  

  • 6. A consensus and state-of-the-art workshop: marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescence.
    Finlay JL; Massimino M
    Pediatr Blood Cancer; 2010 Apr; 54(4):634. PubMed ID: 20146221
    [No Abstract]   [Full Text] [Related]  

  • 7. [The nurse's role in cytostatic treatment of cancer patients].
    Simonetti G; Dreschler JM; Somers R
    Tijdschr Ziekenverpl; 1980 Mar; 33(6):239-49. PubMed ID: 6770488
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of bone marrow cellularity in selective testing of the anti-tumor action of cytostatic drugs. Determination of the optimum of selectivity].
    Rosin S
    Stud Cercet Med Interna; 1967; 8(1):89-96. PubMed ID: 6043548
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myelosuppressive effect of cytostatics in the intensive chemotherapy of solid tumors].
    Kolarić K
    Lijec Vjesn; 1978 Jun; 100(6):378. PubMed ID: 703496
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs and the bone marrow.
    Treleaven J; Barrett J
    Br J Hosp Med; 1990 Oct; 44(4):245-50. PubMed ID: 2249099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action of levamisole on bone marrow repair in patients undergoing anticancer chemotherapy].
    Dujardin P; Lods JC; Cassuto JP; Audoly P
    Therapie; 1976; 31(6):733-8. PubMed ID: 1025779
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro evaluation of myelotoxicity induced by antineoplastic drugs.
    Viano I; Silvestro L; Giaccone G; Compagnoni G; Donadio M; Ferrati P; Dianzani C; Genazzani E
    Chemioterapia; 1986 Jun; 5(3):147-9. PubMed ID: 3013432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Possible inhibitory effect of androgens on bone marrow suppression by cytotoxic agents--a dose-dependent phenomenon?
    Sadoff L; Grossman J
    Cancer Chemother Rep; 1974; 58(2):125-7. PubMed ID: 4857363
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood lysozyme level and bone marrow granulocyte reserve].
    Pellerito R; Agricola R; Giovanelli E; Neretto G
    Arch Sci Med (Torino); 1978; 135(4):485-92. PubMed ID: 756713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of the restorative processes in the bone marrow of animals during the administration of cytostatic preparations].
    Gol'dberg DI; Gol'dberg ED; Karpova FV; Dalinger LM; Golubev IV; Antipov IG; Dedova LS; Koifman EK; Kraiushkina NP; Kim EA; Grimberg LG; Novitskiĭ VV; Makarov AS
    Probl Gematol Pereliv Krovi; 1970 Apr; 15(4):45-51. PubMed ID: 5453831
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy of autologous preserved marrow on patients undergoing myelodepressive therapeutic treatment].
    Polese E; Massenti S; Rossi-Torelli M
    Minerva Med; 1970 Sep; 61(77):4159-62. PubMed ID: 4921987
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of infections in radiation and cytostatic depression of the bone marrow].
    Nadezhina NM; Petrosian LN; Selidovkin GD; Baranov AE
    Med Radiol (Mosk); 1982 Nov; 27(11):32-9. PubMed ID: 6757630
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytostatic drugs--mechanism of action and guidelines for clinical use].
    Sauer H
    Fortschr Med; 1989 Oct; 107(29):604-11. PubMed ID: 2680840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [General patterns of initiation of restorative processes in the destroyed bone marrow of animals following massive doses of cytostatic preparations].
    Gol'dberg DI; Gol'dberg ED; Fedorovich TV
    Biull Eksp Biol Med; 1972 Nov; 73(11):96-9. PubMed ID: 4645188
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of the newly-developed Czechoslovak cytostatic, Benfluron, on the morphology of the blood and bone marrow in laboratory rats].
    Berger J; Nĕmec J
    Cas Lek Cesk; 1986 Aug; 125(31):969-73. PubMed ID: 3731239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.